CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the long-term effectiveness and safety of the R21/Matrix-Malaria vaccine for malaria prevention in children recovering from severe anaemia in sub-Saharan Africa. It aims to extend the duration of malaria protection from 4 to 12 months through a randomized clinical trial.
The overall goal of this project is to provide scientific evidence for WHO policymaking on the longterm efficacy, safety, acceptability and cost-effectiveness of using R21/Matrix-Malaria vaccine to extend the duration of malaria chemoprevention from 4 to 12 months in children recovering from severe anaemia in highly malaria-endemic areas in sub-Saharan Africa.
This project will generate long-term safety and efficacy data and also generate pharmacovigilance data on a currently registered vaccine…
LIVERPOOL SCHOOL OF TROPICAL MEDICINE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
LIVERPOOL SCHOOL OF TROPICAL MEDICINE (KENYA) LIMITED
Kenya, NAIROBI
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
TRAINING & RESEARCH UNIT OF EXCELLENCE LIMITED
Malawi, Blantyre
Type: Research institute
Activity type: Research Organisations
SME: No
Uganda, Kampala
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
